Inventor

Kevin P. Anderson

Inventor

Carlsbad, CA, US

Overview

1995–2006

Patent span

Chemistry

Primary field (CPC C)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Qprimary

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms21%

C12NMicroorganisms or enzymes19%

A61KPreparations for medical, dental or toiletry purposes14%

C07KPeptides14%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%

C07HSugars12%

C12YEnzymes4%

G01NInvestigating or analysing materials by determining their chemical or physical properties3%

A01NPreservation of bodies of humans or animals or plants or parts thereof1%

PatentTitleYear

7,067,497'Modulation of telomere length by oligonucleotides having a G-core sequence'2006 6,995,146'Compositions and methods for treatment of hepatitis C virus-associated diseases'2006 6,608,191'Compositions and methods for treatment of hepatitis C virus-associated diseases'2003 6,433,159'Compositions and methods for treatment of Hepatitis C virus associated diseases'2002 6,423,489'Compositions and methods for treatment of Hepatitis C virus-associated diseases'2002 6,391,542'Compositions and methods for treatment of Hepatitis C virus-associated diseases'2002 6,284,458'Compositions and methods for treatment of hepatitis C virus-associated diseases'2001 6,174,868'Compositions and methods for treatment of hepatitis C virus-associated diseases'2001 6,153,595'Composition and method for treatment of CMV infections'2000 5,985,662'Antisense inhibition of hepatitis B virus replication'1999 5,952,490'Oligonucleotides having a conserved G4 core sequence'1999 5,789,573'Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2'1998 5,698,391'Methods for synthetic unrandomization of oligomer fragments'1997 5,672,472'Synthetic unrandomization of oligomer fragments'1997 5,591,720'Oligonucleotides for modulating the effects of cytomegalovirus infections'1997 5,514,577'Oligonucleotide therapies for modulating the effects of herpes viruses'1996 5,442,049'Oligonucleotides for modulating the effects of cytomegalovirus infections'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2006Patents assigned to ISIS PHARMACEUTICALS INC (17)· patent assignee history

1995–2006Based in Carlsbad, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ISIS PHARMACEUTICALS INC	17	1995–2006

Locations

Location	Patents	Span
Carlsbad, California, US	17	1995–2006